Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion type Assertion NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_head.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion description "[In conjunction with other diagnostic determinants, immunophenotypic analysis of differentially expressed cell surface markers, such as CD5, CD20, CD23 and FMC7, is useful in the subclassification of lymphomas and leukemias arising from the B-cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion evidence source_evidence_literature NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion SIO_000772 12835728 NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion wasDerivedFrom befree-20150227 NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.
- NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_assertion wasGeneratedBy ECO_0000203 NP396412.RAUFz2SHBSzwQ2OQfyKHTIB0JL9TM3M56oGbkqS3jxwVk130_provenance.